Research Topics
| Dominique Charles VallaSummaryCountry: France Publications
| Collaborators
|
Detail Information
Publications
[Jaundice]Dominique-Charles Valla
Dominique-Charles Valla
Rev Prat 55:1607-13. 2005- Ischemic cholangiopathyPierre Deltenre
, , Haine-Saint-Paul, Belgium
J Hepatol 44:806-17. 2006 - Hepatic vein thrombosis (Budd-Chiari syndrome)Dominique Charles Valla
Service d Hepatologie, Hopital Beaujon, 100 Boulevard du General Leclerc, 92118 Clichy, France
Semin Liver Dis 22:5-14. 2002..The current 10-year survival rate is about 75%... - Prognosis in Budd Chiari syndrome after re-establishing hepatic venous drainageD-C Valla
, , , , and INSERM-CR3B, , France
Gut 55:761-3. 2006 - [Hepatic granulomatosis]D-C Valla
, , , 92118 Clichy, France
Rev Med Interne 26:S7-8. 2005 - The diagnosis and management of the Budd-Chiari syndrome: consensus and controversiesDominique-Charles Valla
, , , , 92118 Clichy, France
Hepatology 38:793-803. 2003 - Spectrum of portal vein thrombosis in the WestDominique-Charles Valla
, , , Clichy, France
J Gastroenterol Hepatol 17:S224-7. 2002 - [Acute hypoxic hepatitis, congestive cardiac liver]Dominique-Charles Valla
, , , 92118, Clichy Cedex
Gastroenterol Clin Biol 27:B33-40. 2003 - Clinical characteristics and outcome of patients with cirrhosis and refractory ascitesRichard Moreau
Service d Hépatologie and INSERM U 481, 92118 Clichy, France
Liver Int 24:457-64. 2004..In patients with cirrhosis, refractory ascites is associated with a poor prognosis and is an indication for liver transplantation. However, factors that determine prognosis remain unclear... - Accuracy and disagreement of computed tomography and magnetic resonance imaging for the diagnosis of small hepatocellular carcinoma and dysplastic nodules: role of biopsyThomas Sersté
Assistance Publique Hopitaux de Paris, APHP Service d Hépatologie, Hopital Beaujon, Clichy, France
Hepatology 55:800-6. 2012..These findings are frequently discordant on both CT and MRI, supporting the place of biopsy for the diagnosis of small HCCs... - Prospective evaluation of the management of hepatocellular carcinoma in the elderlyViolaine Ozenne
Department of Hepatology, Hopital Beaujon, AP HP, Clichy, France
Dig Liver Dis 43:1001-5. 2011..Previous studies suggested that ageing does not adversely impact survival but they have the drawback of being retrospective and spanning a prolonged period of time... - Hepatic veins as a site of clot formation following liver resectionEmmanuel Buc
Department of Hepato biliary Surgery, Hopital Beaujon, Assistance Publique Hopitaux de Paris, University Paris 7, 92118 Clichy, France
World J Gastroenterol 17:403-6. 2011..Clots disappeared following curative anticoagulation. We conclude that thrombosis of hepatic veins may occur after liver resection and is a potential source of pulmonary embolism... - Microbial epidemiology and outcome of bloodstream infections in liver transplant recipients: an analysis of 259 episodesFrederic Bert
Department of Microbiology, APHP, Beaujon Hospital, Clichy, France
Liver Transpl 16:393-401. 2010..47). In conclusion, BSIs are frequent and early complications after liver transplantation and are mostly caused by gram-negative bacilli. A BSI in the first posttransplant month is a significant predictor of 1-year survival... - Budd-Chiari syndromeAurelie Plessier
Service d Hepatologie, Hopital Beaujon, Clichy, France
Semin Liver Dis 28:259-69. 2008..This strategy has achieved 5-year survival rates close to 90%... - Telangiectatic adenoma: an entity associated with increased body mass index and inflammationValerie Paradis
Service d Anatomie Pathologique, Hopital Beaujon, Clichy, France
Hepatology 46:140-6. 2007..CONCLUSION: This study has shown that TAs occur in a characteristic background of overweight patients and are often associated with a biological inflammatory syndrome. Moreover, a TA may progress to malignancy... - Incidental focal solid liver lesions: diagnostic performance of contrast-enhanced ultrasound and MR imagingMichael Soussan
Department of Radiology, Assistance Publique des Hopitaux de Paris, APHP, Hopital Beaujon, Clichy, France
Eur Radiol 20:1715-25. 2010..To prospectively assess the diagnostic performance of contrast-enhanced ultrasound (CEUS) and MR imaging in incidental solid focal liver lesions not characterised on ultrasound... - Direct comparison of diagnostic performance of transient elastography in patients with chronic hepatitis B and chronic hepatitis CAna Carolina Cardoso
Service d Hépatologie and INSERM U773 CRB3, Hopital Beaujon, APHP, University of Paris 7, Clichy, France
Liver Int 32:612-21. 2012..A secondary analysis was performed to assess whether or not alanine aminotransferase (ALT) levels would impact on the accuracy of TE... - Primary Budd-Chiari syndromeDominique Charles Valla
Centre de Référence des Maladies Vasculaires du Foie, AP HP, Hopital Beaujon, Service d Hepatologie, Clichy 92118, France
J Hepatol 50:195-203. 2009..Medium-term prognosis depends on the severity of liver disease. Long-term outcome might be jeopardized by transformation of underlying conditions and hepatocellular carcinoma... - Comparison of outcome in patients with cirrhosis and ascites following treatment with albumin or a synthetic colloid: a randomised controlled pilot trailRichard Moreau
Service d Hépatologie and INSERM Unité 481, Hopital Beaujon, Clichy, France
Liver Int 26:46-54. 2006..The question of which colloid (albumin or synthetic colloids) used for plasma expansion following paracentesis or other complications requiring fluid loading in patients with cirrhosis remains controversial... - Significant gene expression differences in histologically "Normal" liver biopsies: Implications for control tissueTarik Asselah
Service d Hépatologie and Institut National de la Santé et de la Recherche Médicale INSERM U733, CRB3, Universite Paris Diderot, Assistance Publique Hopitaux de Paris, Hopital Beaujon, Clichy, France
Hepatology 48:953-62. 2008.... - Management of hepatic vascular diseasesAurelie Plessier
Pôle des Maladies de l Appareil Digestif, Service d Hepatologie, Centre de Référence des Maladies Vasculaires du Foie, Hopital Beaujon, AP HP, Clichy, France
J Hepatol 56:S25-38. 2012..Anticoagulation should be considered. (vi) Nodular regenerative hyperplasia is induced by the uneven perfusion due to obstructed sinusoids, or portal or hepatic venules. It causes pure portal hypertension... - Thrombosis and anticoagulation in liver diseaseDominique Charles Valla
, , , , , and INSERM U773-CRB3, Clichy, France
Hepatology 47:1384-93. 2008 - Suspected interaction between sorafenib and HAART in an HIV-1 infected patient: a case reportViolaine Ozenne
Service d Hepatologie, Hopital Beaujon, APHP, Clichy, France
Hepatogastroenterology 58:161-2. 2011..Interactions between sorafenib and highly active antiretroviral therapy (HAART) have not been studied yet. We report a case of serious adverse effects in anHIV-1 patient co-infected with HBV... - Risk factors for Clostridium difficile infection in a hepatology wardDominique Vanjak
Unite d Hygiene et de Lutte contre les Infections Nosocomiales, Hopital Beaujon, Clichy, France
Infect Control Hosp Epidemiol 28:202-4. 2007..9%). Since strain typing ruled out a clonal dissemination, we performed a case-control study. In addition to antibiotic use as a risk factor, the C. difficile infection rate was higher among patients with autoimmune hepatitis (P<.01)... - Pathogenesis and treatment of Budd-Chiari syndrome combined with portal vein thrombosisSarwa Darwish Murad
Department of Gastroenterology and Hepatology, Erasmus University Medical Center Rotterdam, Rotterdam, The Netherlands
Am J Gastroenterol 101:83-90. 2006..These results strongly support a liberal use of anticoagulants, which so far had been widely debated. Alternatively, derivative shunt procedures appear difficult, yet not impossible... - Vascular disorders of the liverDominique-Charles Valla
, , UFR Xavier Bichat, , et INSERM U481, , Clichy
Acta Gastroenterol Belg 66:294-7. 2003 - Can the model for end-stage liver disease be used to predict the prognosis in patients with Budd-Chiari syndrome?Sarwa Darwish Murad
Department of Gastroenterology and Hepatology, Erasmus University Medical Center Rotterdam, Rotterdam, The Netherlands
Liver Transpl 13:867-74. 2007..65-0.85). In conclusion, MELD showed a suboptimal discriminative ability to predict survival in BCS. This was explained by the highly variable degree of liver dysfunction and hence clinical outcome in BCS in contrast to ESLD... - Determinants of survival and the effect of portosystemic shunting in patients with Budd-Chiari syndromeSarwa Darwish Murad
Department of Gastroenterology and Hepatology, Erasmus Medical Center Rotterdam, Rotterdam, The Netherlands
Hepatology 39:500-8. 2004..Our results suggest an improved survival after surgical portosystemic shunting for patients with an intermediate prognosis (class II)... - Clinical course, predictive factors and prognosis in patients with cirrhosis and type 1 hepatorenal syndrome treated with Terlipressin: a retrospective analysisIsabelle Colle
Laboratoire d Hémodynamique Splanchmique et de Biologie Vasculaire, Institut National de la Santé et de la Recherge Médicale, Clinchy, France
J Gastroenterol Hepatol 17:882-8. 2002..The aim of the present retrospective study was to investigate the predictive factors and prognosis of patients with type 1 HRS treated with terlipressin... - [Gastrointestinal hemorrhage. What kind of surveillance is needed for drug treatment?]Dominique-Charles Valla
, , AP-HP, Clichy
Gastroenterol Clin Biol 28:B242-55. 2004